HERITAGE

Serial Number 85029967
Registration 3910537
800

Registration Progress

Application Filed
May 4, 2010
Under Examination
Approved for Publication
Nov 9, 2010
Published for Opposition
Nov 9, 2010
Registered
Jan 25, 2011

Trademark Image

HERITAGE

Basic Information

Serial Number
85029967
Registration Number
3910537
Filing Date
May 4, 2010
Registration Date
January 25, 2011
Published for Opposition
November 9, 2010
Renewal Date
January 25, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 17, 2020
Registration
Registered
Classes
005

Rights Holder

Heritage Pharmaceuticals Inc.

03
Address
Suite 1700
One Tower Central Blvd.
East Brunswick, NJ 08816

Ownership History

Heritage Pharmaceuticals Inc.

Original Applicant
03
Edison, NJ

Heritage Pharmaceuticals Inc.

Owner at Publication
03
Edison, NJ

Heritage Pharmaceuticals Inc.

Original Registrant
03
East Brunswick, NJ

Legal Representation

Attorney
Matthew A. Homyk

USPTO Deadlines

Next Deadline
2006 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2011-01-25)
Due Date
January 25, 2031
Grace Period Ends
July 25, 2031

Application History

36 events
Date Code Type Description Documents
Jul 17, 2020 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Jul 17, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jul 17, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jul 17, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jul 15, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 9, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
May 8, 2020 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Jan 25, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Mar 22, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 22, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 22, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 20, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Sep 28, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 28, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 25, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 9, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 9, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 6, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 5, 2010 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 30, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 30, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 30, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 29, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 29, 2010 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 29, 2010 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 10, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 3, 2010 ALIE A ASSIGNED TO LIE Loading...
Aug 17, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 14, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 14, 2010 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 14, 2010 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 12, 2010 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
May 11, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 7, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Anywhere: Dec 16, 2006
First Use in Commerce: Dec 16, 2006

Additional Information

Design Mark
The mark consists of The mark consists of HERITAGE displayed in white in a blue rectangular box with rounded corners and a trimmed white border.
Color Claim
The color(s) blue and white is/are claimed as a feature of the mark.
Other
In the statement, a color claim and mark description are inserted. The drawing is amended to appear as follows: PUBLISH CUT

Classification

International Classes
005